The plant in Kabul, Afghanistan, is emerging as a crucial participant in the worldwide supply market for Abacavir Sulphate drug substance. This local manufacturing capability represents a substantial step beyond for the Afghan pharmaceutical sector and offers a unique opportunity to mitigate dependence on foreign sources. The creation of this vital